XML 43 R58.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Parent Company Financial Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Parent Company Financial Information [Abstract] |
Parent Company Financial Information | Condensed Balance Sheets
|  | December 31, |
(In thousands) |  | 2019 |  |  | 2018 |
Assets |  |  |  |  |  |
Cash and cash equivalents |  | $ | 9,387 |  |  | $ | 5,876 |
Equity securities, at estimated fair value |  |  | 22,441 |  |  |  | 18,221 |
Investment in subsidiaries, on equity basis |  |  | 1,209,752 |  |  |  | 1,117,350 |
Other assets |  |  | 30,855 |  |  |  | 34,237 |
Total assets |  | $ | 1,272,435 |  |  | $ | 1,175,684 |
Liabilities and Stockholders’ Equity |  |  |  |  |  |  |  |
Total liabilities |  | $ | 152,038 |  |  | $ | 157,775 |
Stockholders’ equity |  |  | 1,120,397 |  |  |  | 1,017,909 |
Total liabilities and stockholders’ equity |  | $ | 1,272,435 |  |  | $ | 1,175,684 |
Condensed Statements of Income
|  | Years ended December 31, |
(In thousands) |  | 2019 |  |  | 2018 |  |  | 2017 |
Dividends from subsidiaries |  | $ | 50,200 |  |  | $ | 43,000 |  |  | $ | 38,300 |
Management fee from subsidiaries |  |  | 7,981 |  |  |  | 7,907 |  |  |  | 99,319 |
Net securities gains |  |  | 165 |  |  |  | 399 |  |  |  | 2,237 |
Interest, dividends and other income |  |  | 876 |  |  |  | 905 |  |  |  | 928 |
Total revenue |  | $ | 59,222 |  |  | $ | 52,211 |  |  | $ | 140,784 |
Operating expenses |  |  | 14,262 |  |  |  | 14,226 |  |  |  | 100,667 |
Income before income tax benefit and equity in undistributed income of subsidiaries |  | $ | 44,960 |  |  | $ | 37,985 |  |  | $ | 40,117 |
Income tax (benefit) expense |  |  | (1,588 | ) |  |  | (1,608 | ) |  |  | 2,233 |
Dividends in excess of income (equity in undistributed income) of subsidiaries |  |  | 74,473 |  |  |  | 72,973 |  |  |  | 44,267 |
Net income |  | $ | 121,021 |  |  | $ | 112,566 |  |  | $ | 82,151 |
Condensed Statements of Cash Flow
|  | Years ended December 31, |
(In thousands) |  | 2019 |  |  | 2018 |  |  | 2017 |
Operating activities |  |  |  |  |  |  |  |  |
Net income |  | $ | 121,021 |  |  | $ | 112,566 |  |  | $ | 82,151 |
Adjustments to reconcile net income to net cash provided by operating activities |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization of premises and equipment |  |  | 2,298 |  |  |  | 2,814 |  |  |  | 2,974 |
Excess tax benefit on stock-based compensation |  |  | (409 | ) |  |  | (543 | ) |  |  | (1,769 | )
Stock-based compensation expense |  |  | 4,210 |  |  |  | 3,936 |  |  |  | 3,644 |
Net securities gains |  |  | (165 | ) |  |  | (399 | ) |  |  | (2,238 | )
Re-evaluation of deferred tax amounts from Tax Act |  |  | - |  |  |  | - |  |  |  | 3,339 |
Equity in undistributed income of subsidiaries |  |  | (124,673 | ) |  |  | (115,972 | ) |  |  | (82,567 | )
Cash dividend from subsidiaries |  |  | 50,200 |  |  |  | 43,000 |  |  |  | 38,300 |
Bank owned life insurance income |  |  | (398 | ) |  |  | (424 | ) |  |  | (328 | )
Net change in other assets and other liabilities |  |  | (1,573 | ) |  |  | (6,124 | ) |  |  | (2,454 | )
Net cash provided by operating activities |  | $ | 50,511 |  |  | $ | 38,854 |  |  | $ | 41,052 |
Investing activities |  |  |  |  |  |  |  |  |  |  |  |
Proceeds on sales of equity securities |  | $ | - |  |  | $ | 3,318 |  |  | $ | - |
Purchases of equity securities |  |  | (93 | ) |  |  | (2 | ) |  |  | - |
Proceeds on sales and maturities of AFS securities |  |  | - |  |  |  | - |  |  |  | 4,710 |
Purchases of AFS securities |  |  | - |  |  |  | - |  |  |  | (9 | )
Proceeds from settlement of bank owned life insurance |  |  | - |  |  |  | - |  |  |  | 308 |
Net purchases of premises and equipment |  |  | - |  |  |  | - |  |  |  | (2,264 | )
Net cash (used in) provided by investing activities |  | $ | (93 | ) |  | $ | 3,316 |  |  | $ | 2,745 |
Financing activities |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from the issuance of shares to employee and other stock plans |  | $ | 725 |  |  | $ | 1,296 |  |  | $ | 3,309 |
Cash paid by employer for tax-withholding on stock issuance |  |  | (1,622 | ) |  |  | (1,893 | ) |  |  | (3,582 | )
Cash dividends |  |  | (46,010 | ) |  |  | (43,269 | ) |  |  | (40,104 | )
Net cash (used in) financing activities |  | $ | (46,907 | ) |  | $ | (43,866 | ) |  | $ | (40,377 | )
Net increase (decrease) in cash and cash equivalents |  | $ | 3,511 |  |  | $ | (1,696 | ) |  | $ | 3,420 |
Cash and cash equivalents at beginning of year |  |  | 5,876 |  |  |  | 7,572 |  |  |  | 4,152 |
Cash and cash equivalents at end of year |  | $ | 9,387 |  |  | $ | 5,876 |  |  | $ | 7,572 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration